Holen Sie sich die Stockscreener-App
25.00
0.92%
0.12
Handel nachbörslich:
24.57
-0.43
-1.72%
Schlusskurs vom Vortag:
$24.88
Offen:
$25.7
24-Stunden-Volumen:
900.77K
Relative Volume:
0.57
Marktkapitalisierung:
$1.96B
Einnahmen:
$1.29B
Nettoeinkommen (Verlust:
$58.52M
KGV:
38.30
EPS:
0.6528
Netto-Cashflow:
$191.78M
1W Leistung:
+2.07%
1M Leistung:
+38.19%
6M Leistung:
-5.96%
1J Leistung:
+22.37%
1-Tages-Spanne:
$24.92
$25.80
1-Wochen-Bereich:
$24.14
$25.90
52-Wochen-Spanne:
$16.10
$28.75
Progyny Inc Stock (PGNY) Company Profile
Firmenname
Progyny Inc
Sektor
Branche
Telefon
212-888-3124
Adresse
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
25.04 | 1.95B | 1.29B | 58.52M | 191.78M | 0.6528 |
UNH
Unitedhealth Group Inc
|
376.87 | 352.79B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
90.83 | 118.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
387.82 | 85.71B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
280.97 | 75.72B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
301.75 | 36.97B | 137.20B | 1.15B | 1.27B | 9.3439 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-12 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-08 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Herabstufung | Truist | Buy → Hold |
| 2024-09-19 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Eingeleitet | BTIG Research | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Eingeleitet | Truist | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Berenberg | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Overweight |
| 2021-06-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-02 | Eingeleitet | Guggenheim | Buy |
| 2019-11-19 | Eingeleitet | Citigroup | Buy |
| 2019-11-19 | Eingeleitet | Goldman | Buy |
| 2019-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-11-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-11-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Progyny Inc Aktie (PGNY) Neueste Nachrichten
Progyny, Inc. authorizes a Buyback Plan. - marketscreener.com
Progyny, Inc. announces an Equity Buyback for $200 million worth of its shares. - marketscreener.com
Progyny announces $200M share repurchase program funded from cash - TradingView
Progyny (PGNY) board authorizes cash-funded $200 million stock buyback - Stock Titan
Progyny authorizes $200 million share buyback program - Investing.com
Women’s health firm Progyny launches $200M stock buyback plan - Stock Titan
Progyny, Inc. Announces Share Repurchase Program - Yahoo Finance
Progyny (PGNY) Is Up 7.0% After Analyst Upgrade Backed By Six Earnings Beats And 2026 Outlook - Yahoo Finance
Does Progyny (PGNY) Still Deserve a Premium Narrative After Its Latest Growth Upgrade and Conference Spotlight? - simplywall.st
Fertility benefits growth and share buybacks keep Progyny (PGNY) earnings in focus - MSN
[144] Progyny, Inc. SEC Filing - Stock Titan
Progyny Inc Annual Shareholders Meeting Transcript - GuruFocus
Progyny Inc (PGNY) Stock Down 3.8% -- Now Undervalued? GF Score: 87/100 - GuruFocus
Insider Sell Alert: Mark Livingston Sells Shares of Progyny Inc (PGNY) - GuruFocus
Progyny CFO Mark S. Livingston sells $211,012 of common stock By Investing.com - Investing.com Australia
Progyny CFO Mark S. Livingston sells $211,012 of common stock - Investing.com
Transcript : Progyny, Inc.Shareholder/Analyst Call - marketscreener.com
Progyny (PGNY) CFO sells 8,275 shares under Rule 10b5-1 plan - Stock Titan
Progyny (PGNY) COO Melissa Cummings sells 9,578 shares under 10b5-1 plan - Stock Titan
Progyny stock (US74340E1038): insider share sale filing puts focus on fertility benefits specialist - AD HOC NEWS
Progyny (PGNY) Stock Is Up, What You Need To Know - Yahoo Finance
PGNY Technical Analysis | Trend, Signals & Chart Patterns | PROGYNY INC (NASDAQ:PGNY) - ChartMill
Bull of the day: Progyny (PGNY) - MSN
Notice of proposed sale for PGNY (NASDAQ: PGNY) with recent RSU vesting - Stock Titan
Positive Report for Progyny (PGNY) from Goldman Sachs - The Globe and Mail
CCORF Maintains Progyny(PGNY.US) With Buy Rating, Maintains Target Price $30 - Moomoo
PGNY Upgraded by Canaccord Genuity -- Price Target Raised to $30 - GuruFocus
Dow Theory LettersProgyny (PGNY) Stock Is Up, What You Need To Know - FinancialContent
This Stubhub Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday - Benzinga
Canaccord upgrades Progyny stock rating to buy on guidance beat streak - Investing.com Nigeria
Canaccord Genuity Upgrades Progyny to Buy From Hold, Adjusts PT to $30 From $19 - Moomoo
Canaccord upgrades Progyny stock rating to buy on guidance beat streak By Investing.com - Investing.com South Africa
Responsive Playbooks and the PGNY Inflection - Stock Traders Daily
Canaccord Genuity upgrades Progyny (PGNY) - MSN
Progyny Is Maintained at Overweight by Barclays - Moomoo
Progyny (PGNY) Stock Forecast & Analyst Ratings - Moomoo
Progyny and Standex International have been highlighted as Zacks Bull and Bear of the Day - Zacks Investment Research
Bull of the Day: Progyny (PGNY) - InteractiveCrypto
Progyny’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
US proposes rule for employer-sponsored fertility benefits - MSN
Progyny stock (US74340E1038): fertility benefits specialist back in focus after strong quarterly update - facilitiesmanagement-now.com
Progyny, Inc. $PGNY Shares Sold by Thrivent Financial for Lutherans - MarketBeat
Progyny stock (US74340E1038): fertility benefits specialist back in focus after strong quarterly upd - AD HOC NEWS
The Strong Earnings Posted By Progyny (NASDAQ:PGNY) Are A Good Indication Of The Strength Of The Business - Sahm
Progyny stock (US74340E1038): fertility benefits specialist back in focus after latest business upda - AD HOC NEWS
Shareholders Will Be Pleased With The Quality of Progyny's (NASDAQ:PGNY) Earnings - Yahoo Finance
Progyny Q1 earnings call highlights - MSN
Progyny Inc (NASDAQ:PGNY): A GARP Play with Balanced Growth and Valuation - ChartMill
Progyny (PGNY) Q1 Earnings and Revenues Beat Estimates - Eastern Progress
Finanzdaten der Progyny Inc-Aktie (PGNY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):